RAPT Therapeutics (RAPT) Leases: 2022-2024
Historic Leases for Therapeutics (RAPT) over the last 3 years, with Sep 2024 value amounting to $3.8 million.
- Therapeutics' Leases fell 32.56% to $3.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.8 million, marking a year-over-year decrease of 32.56%. This contributed to the annual value of $5.2 million for FY2023, which is 24.67% down from last year.
- Per Therapeutics' latest filing, its Leases stood at $3.8 million for Q3 2024, which was down 11.13% from $4.3 million recorded in Q2 2024.
- Therapeutics' Leases' 5-year high stood at $6.9 million during Q4 2022, with a 5-year trough of $3.8 million in Q3 2024.
- Over the past 3 years, Therapeutics' median Leases value was $5.8 million (recorded in 2022), while the average stood at $5.6 million.
- In the last 5 years, Therapeutics' Leases rose by 3.23% in 2023 and then crashed by 32.56% in 2024.
- Quarterly analysis of 3 years shows Therapeutics' Leases stood at $6.9 million in 2022, then declined by 24.67% to $5.2 million in 2023, then plummeted by 32.56% to $3.8 million in 2024.
- Its last three reported values are $3.8 million in Q3 2024, $4.3 million for Q2 2024, and $4.8 million during Q1 2024.